|Articles|July 1, 2012
- Pharmaceutical Executive-07-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - July 2012
2012 Emerging Pharma Leaders
Advertisement
Articles in this issue
over 13 years ago
Emerging Pharma Leaders 2012over 13 years ago
Who Will Pay for New Drugs?over 13 years ago
Less, But Betterover 13 years ago
John Lechleiter on PhRMA and Innovationover 13 years ago
The Learning Curveover 13 years ago
Marketing: Why the Conversation Has Changed — ForeverNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer
2
Pharma Partnerships Expand as Eli Lilly Announces Strategic Collaborations with MeiraGTx and SanegeneBio
3
Wegovy Demonstrates Reduction in Liver Injury in MASH Patients
4
CMS Unveils Initiative to Cut Medicaid Drug Costs and Expand Access to Affordable Medications
5
